SeroVital-hgh
Allegations: Falsely marketing that supplements increase human growth hormone (HGH) levels by 682%, make users look decades younger, and provide various anti-aging benefits
SeroVital-hgh Supplements
December 2023: The lawsuit was transferred from a court in California to a court in Utah. (Case No. 23-cv-889, D. Utah)
May 2022: Plaintiffs filed an amended complaint.
May 2018: A class-action lawsuit was filed against SanMedica International for allegedly falsely advertising the Human Growth Hormone (HGH) supplement SeroVital-hgh. Specifically, plaintiffs claim that SanMedica falsely markets the supplement as able to increase HGH levels by 682% when, according to the complaint, it does increase HGH levels at all. In addition, the complaint alleges that the supplement reduces wrinkles, decreases body fat, increases lean muscle mass, makes stronger bones, improves mood, and heightens sex drive when, according to plaintiffs, the product does not provide any of these benefits. (Pizana et al v. SanMedica International, LLC, Case No. 18-cv-644, E.D. Cal.)
For more of TINA.org’s coverage of SeroVital-hgh, click here.
Class-Action Tracker
The Latest
Skull Shaver’s Early Bird Sale
Trying to take advantage of this sale may not be as smooth as advertised.
Roblox Bid for Ad Riches Collides With Wary Sponsors, Developers
Cecilia D’Anastasio, Bloomberg
UIC Aspire Grant
TINA.org digs into school’s debt-free claims.
TINA.org Joins Consumer Advocates to Keep FTC Bipartisan
Why agency independence is in the best interests of consumers.
Tracksmith’s ‘100 Mile Guarantee’
What exactly does this running brand mean by “your return is on us”?